Combinatorial regulation of the enhancer codes in senescence
衰老过程中增强子密码的组合调控
基本信息
- 批准号:10152492
- 负责人:
- 金额:$ 54.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActivinsAddressAgingAppearanceAreaBindingBiologyCRISPR interferenceCell AgingCellsCodeDNA BindingDataDevelopmentEnhancersEventFeedbackGenetic TranscriptionGenomicsGoalsGrowth FactorHomeostasisIn VitroKnowledgeLaboratoriesLicensingMADH2 geneModalityMolecularMotionOutcome StudyPathologicPathologyPeptide HydrolasesPhenotypeProcessProductionRegulationResearchResponse ElementsRoleSeminalSeriesSignal PathwaySignal TransductionSirolimusTestingWithdrawalWorkactivating transcription factorbasecell growth regulationcell typechemokinechromatin remodelingcohortcombinatorialcytokineepigenomicshealthy aginghistone modificationin vivoinhibitor/antagonistinsightmTOR Inhibitornovelnovel therapeuticsoutcome predictionprogramsresponsescreeningsenescencetranscription factor
项目摘要
Abstract
Based on the importance of defining new insights into cellular senescence, we initiated studies to investigate
whether there might be a specific enhancer activation “code” that underlies cellular senescence for
identifying the responsible DNA binding transcription factors. While there is rapidly-emerging, and now
unassailable evidence, on the role of the 40-70,000 enhancers in each cell type in development, homeostasis
and, often, pathological events, their role in cellular senescence remains undefined. Furthermore, while cellular
senescence represents a fundamental process of aging and a known driver of pathologies, the causative role of
newly activated enhancer cohorts underlying progression of senescence remain poorly understood. Therefore,
the goal of this proposal, supported by extensive preliminary data, is to test a novel hypothesis that the de
novo appearance of two specific cohorts of enhancers sets into motion a progressive, functionally-
important, alteration in gene transcription programs. Based on our study of the altered enhancer and
chromosomal landscape during replicative senescence, we have begun to establish that the geroprotective
mTOR inhibitor, Rapamycin, markedly delays all aspects of cellular senescence, including the appearance
of new, functional, enhancers. Our focus is to elucidate the functional importance of a gained enhancer program
underlying cellular senescence, and identify the critical DNA binding transcription factors underlying the
transcriptional programs that are determinants of replicative senescence, based on the complementary expertise
of the Suh and Rosenfeld laboratories. Specifically: i) We will use unbiased screens to document that at least
two distinct activated enhancer networks independently regulate the proliferation arrest and SASP aspects
of replicative senescence, respectively. ii) We will identify combinatorial factors synergizing with the
previously-unrecognized transcription factors, NFI-A, NFI-C, to regulate the gained enhancers underling
proliferation arrest, and those that, with SMAD2/3 and NFkB, to regulate the SASP program. In parallel, we
can implicate the underlying signaling pathways. iii) We will identify previously unrecognized histone
modification signatures of, and their functional importance in replicative senescence . iv) We will Identify
Activin and Tgf2 as inhibitors of the proliferation and SASP enhancer programs, respectively. Our proposal
promises to provide transformative insights into molecular events that initiate and perpetuate the senescent cell
phenotypes, and help elucidate potential novel therapeutic modalities against the deleterious SASP program.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL G ROSENFELD其他文献
MICHAEL G ROSENFELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL G ROSENFELD', 18)}}的其他基金
Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease
病毒 IncRNA 调节与散发性阿尔茨海默病相关的宿主基因组转录程序
- 批准号:
10446865 - 财政年份:2022
- 资助金额:
$ 54.59万 - 项目类别:
Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease
病毒 IncRNA 调节与散发性阿尔茨海默病相关的宿主基因组转录程序
- 批准号:
10650398 - 财政年份:2022
- 资助金额:
$ 54.59万 - 项目类别:
Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapy
揭示 HSV1 裂解转录物和潜伏转录物在 AD 发病机制和治疗中的作用
- 批准号:
10621810 - 财政年份:2021
- 资助金额:
$ 54.59万 - 项目类别:
A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction
心肌细胞中应激诱导的启动子暂停释放程序可预防心肌梗死
- 批准号:
10521252 - 财政年份:2019
- 资助金额:
$ 54.59万 - 项目类别:
A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction
心肌细胞中应激诱导的启动子暂停释放程序可预防心肌梗死
- 批准号:
10318093 - 财政年份:2019
- 资助金额:
$ 54.59万 - 项目类别:
Combinatorial regulation of the enhancer codes in senescence
衰老过程中增强子密码的组合调控
- 批准号:
10017129 - 财政年份:2019
- 资助金额:
$ 54.59万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 54.59万 - 项目类别:
Research Grant